[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# ![$imrx Graphic](https://lunarcrush.com/gi/w:26/t:$imrx.png) $imrx

$IMRX stock sees increased attention with insider buys and institutional interest, but sentiment remains low. Wall Street eyes the stock as revenue more than doubles YoY.

### About $imrx
Social media analysis of the stock ticker $IMRX, likely representing a biotechnology or pharmaceutical company.  

### Insights [#](/topic/$imrx/insights)
- $imrx posts created is up XXXXX% from the previous week.

### Engagements: XXXXX [#](/topic/$imrx/interactions)
---
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/t:$imrx/c:line/m:interactions/iv:1d.svg)  
[Engagements 24-Hour Time-Series Raw Data](/topic/$imrx/time-series/interactions.tsv)  
**Current Value**: XXXXX  
**Daily Average**: XXXXX  
**1 Week**: XXXXXX -XX%  
**1 Month**: XXXXXXX -XX%  
**1-Year High**: XXXXXX on 2025-06-18  
**1-Year Low**: XXX on 2025-10-05  

| Social Network | X     | YouTube |
| -------------- | -     | ------- |
| Engagements    | XXXXX | X       |
  

  
  
### Mentions: XX [#](/topic/$imrx/posts_active)
---
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/t:$imrx/c:line/m:posts_active/iv:1d.svg)  
[Mentions 24-Hour Time-Series Raw Data](/topic/$imrx/time-series/posts_active.tsv)  
**Current Value**: XX  
**Daily Average**: XXX  
**1-Year High**: XXXXX on 2025-07-09  
**1-Year Low**: X on 2025-04-27  

| Social Network | X  | YouTube |
| -------------- | -  | ------- |
| Mentions       | XX | X       |
  

  
  
### Creators: XX [#](/topic/$imrx/contributors_active)
---
![Creators Line Chart](https://lunarcrush.com/gi/w:600/t:$imrx/c:line/m:contributors_active/iv:1d.svg)  
[Creators 24-Hour Time-Series Raw Data](/topic/$imrx/time-series/contributors_active.tsv)  
XX unique social accounts have posts mentioning $imrx in the last XX hours which is up XX% from XX in the previous XX hours
**Daily Average**: XX  
**1-Year High**: XXXXX on 2025-07-08  
**1-Year Low**: X on 2025-04-27  

The most influential creators that mention $imrx in the last XX hours

| Creator                                              | Rank | Followers | Posts | Engagements |
| -------                                              | ---- | --------- | ----- | ----------- |
| [@SkipperDoodle3](/creator/twitter/SkipperDoodle3)   | X    | XXX       | X     | XXX         |
| [@Quantumup1](/creator/twitter/Quantumup1)           | X    | XXXXX     | X     | XXX         |
| [@DalvinVarnado](/creator/twitter/DalvinVarnado)     | X    | XXXXXX    | X     | XXX         |
| [@BioValues](/creator/twitter/BioValues)             | X    | XXXXX     | X     | XX          |
| [@Elisabe66802172](/creator/twitter/Elisabe66802172) | X    | XXX       | X     | XX          |

[View More](/list/creators/$imrx/100)
  
  
### Sentiment: XX% [#](/topic/$imrx/sentiment)
---
![Sentiment Line Chart](https://lunarcrush.com/gi/w:600/t:$imrx/c:line/m:sentiment/iv:1d.svg)  
[Sentiment 24-Hour Time-Series Raw Data](/topic/$imrx/time-series/sentiment.tsv)  
**Current Value**: XX%  
**Daily Average**: XX%  
**1 Week**: XXX% no change  
**1 Month**: XX% +16%  
**1-Year High**: XXX% on 2025-04-27  
**1-Year Low**: XX% on 2025-09-18  

**Most Supportive Themes**
- **Positive Valuation and Pipeline Advancements:** (40%) Posts highlight the undervaluation of $IMRX, citing strong revenue growth and advancements in its pipeline, particularly in oncology.
- **Insider Activity and Institutional Interest:** (30%) Mentions of insider buys and institutional investments, such as Fidelity and HBM Healthcare, suggest confidence in the company's future.
  
**Most Critical Themes**
- **Unclear if the company is a good investment:** (10%)  Some posts question the company's decisions and the rationale behind certain financial moves, such as the fundraising from SNY.
  
Network engagement breakdown:  
| Network | Positive | %   | Neutral | %   | Negative | %  |
| ------- | -------- | -   | ------- | -   | -------- | -  |
| X       | XXXXX    | XX% | XXX     | XX% | XX       | X% |
| YouTube | X        | X%  | X       | X%  | X        | X% |
|         |          |     |         |     |          |    |
| Total   | XXXXX    | XX% | XXX     | XX% | XX       | X% |
  


**Top assets mentioned**
In the posts about $imrx in the last XX hours

[Sanofi (SNY)](/topic/sanofi)
[Synthetify (SNY)](/topic/$sny)
[BridgeBio Pharma, Inc. Common Stock (BBIO)](/topic/$bbio)
[uniQure N.V. (QURE)](/topic/$qure)
[Pfizer, Inc. (PFE)](/topic/$pfe)
[Home Depot, Inc. (HD)](/topic/$hd)
[Ethereum (ETH)](/topic/ethereum)
[Revolution Medicines, Inc. Common Stock (RVMD)](/topic/$rvmd)
[Regeneron Pharmaceuticals Inc (REGN)](/topic/regeneron-pharmaceuticals-inc)
[Regeneron Pharmaceuticals Inc (REGN)](/topic/$regn)

**Top topics mentioned**
In the posts about $imrx in the last XX hours

[stocks healthcare](/topic/stocks-healthcare), [sanofi](/topic/sanofi), [$sny](/topic/$sny), [stocks](/topic/stocks), [$bbio](/topic/$bbio), [$pmnt](/topic/$pmnt), [$stkh](/topic/$stkh), [$iobt](/topic/$iobt), [$pgen](/topic/$pgen), [$tnon](/topic/$tnon), [$aptc](/topic/$aptc), [$vmar](/topic/$vmar), [$imrxs](/topic/$imrxs), [insider](/topic/insider), [upside](/topic/upside), [$25m](/topic/$25m), [$omic](/topic/$omic), [$bcab](/topic/$bcab), [$artv](/topic/$artv), [$qure](/topic/$qure), [$118k](/topic/$118k), [$tgen](/topic/$tgen), [$pfe](/topic/$pfe), [stocks consumer cyclical](/topic/stocks-consumer-cyclical), [$hd](/topic/$hd), [$fubo](/topic/$fubo), [stocks technology](/topic/stocks-technology), [$sprb](/topic/$sprb), [wall street](/topic/wall-street), [ethereum](/topic/ethereum), [coins layer 1](/topic/coins-layer-1), [$rvmd](/topic/$rvmd), [phd](/topic/phd), [momentum](/topic/momentum), [$200m](/topic/$200m), [$mtnb](/topic/$mtnb), [$pepg](/topic/$pepg), [$lxeo](/topic/$lxeo), [regeneron pharmaceuticals inc](/topic/regeneron-pharmaceuticals-inc), [$regn](/topic/$regn), [investment](/topic/investment), [$1s](/topic/$1s), [$ifrx](/topic/$ifrx), [$vsee](/topic/$vsee), [$whwk](/topic/$whwk), [$buru](/topic/$buru), [$abve](/topic/$abve), [$rvmds](/topic/$rvmds), [$72keeps](/topic/$72keeps), [$zlab](/topic/$zlab), [$78reitd](/topic/$78reitd), [$qtih](/topic/$qtih), [$wstl](/topic/$wstl), [nasdaq](/topic/nasdaq), [$625m](/topic/$625m), [$nvo](/topic/$nvo), [$mrk](/topic/$mrk), [stocks communication services](/topic/stocks-communication-services), [make a](/topic/make-a), [$ryde](/topic/$ryde), [$nwgl](/topic/$nwgl), [$kwe](/topic/$kwe), [$ptle](/topic/$ptle), [$apvo](/topic/$apvo), [$qnrx](/topic/$qnrx), [$asmb](/topic/$asmb), [$rani](/topic/$rani), [$49m](/topic/$49m), [$20m](/topic/$20m), [market cap](/topic/market-cap), [$95m](/topic/$95m), [25m](/topic/25m), [$kb](/topic/$kb), [$ldi](/topic/$ldi), [$uwmc](/topic/$uwmc), [$sei](/topic/$sei), [$open](/topic/$open), [$axsm](/topic/$axsm), [$nvct](/topic/$nvct), [bulls](/topic/bulls), [positions](/topic/positions), [$lqda](/topic/$lqda), [vids](/topic/vids), [stocks financial services](/topic/stocks-financial-services), [subscription](/topic/subscription), [usdt](/topic/usdt), [$dgnx](/topic/$dgnx), [$gnty](/topic/$gnty), [$coop](/topic/$coop), [coins algorand](/topic/coins-algorand), [$mrkr](/topic/$mrkr), [$prok](/topic/$prok), [primary market](/topic/primary-market), [$syn](/topic/$syn), [coins defi](/topic/coins-defi), [coins bsc](/topic/coins-bsc), [coins solana ecosystem](/topic/coins-solana-ecosystem), [$prvb](/topic/$prvb), [$10s](/topic/$10s), [frog](/topic/frog)

### Top Social Posts [#](/topic/$imrx/posts)
---
Top posts by engagements in the last XX hours

*Showing only X posts for non-authenticated requests. Use your API key in requests for full results.*

"Wall Street Eyes Are on $IMRX Revenue more than doubled YoY; pipeline spans IMM-1-104 and IMM-6-415 with multiple readouts ahead. Narrowing burn rate supports progress. Full breakdown in our"  
[X Link](https://x.com/carroll_jody/status/1979954574292292078) [@carroll_jody](/creator/x/carroll_jody) 2025-10-19T16:55Z XXX followers, XX engagements


"Wall Street traders wont tell you this $IMRX raised $25M via direct offering to advance Phase 1/2 trials in KRAS-driven cancers. Cash runway now extended into 2026. Group guiding this stock full details"  
[X Link](https://x.com/ShigematsuHeidi/status/1979954439898439909) [@ShigematsuHeidi](/creator/x/ShigematsuHeidi) 2025-10-19T16:54Z XXX followers, XX engagements


"$IMRX Valuation Is Completely Undervalued Immuneering (IMRX) posted FY24 revenue of $4.9M (+140% YoY) vs $2.0M last year. Market cap near $95M with PS 19x undervalued vs oncology biotech peers advancing pipelines. Group has locked this stock entry price inside"  
[X Link](https://x.com/babiru36/status/1979954362131853525) [@babiru36](/creator/x/babiru36) 2025-10-19T16:54Z 1961 followers, XX engagements


"(2) "The Field" does offer some clarity on these moves from $QURE $QNRX $ASMB $RANI and even $SPRB. The valuations are now absurd with nothing behind it. The mkt maintains contrarian running what has no business running. And dogging the only one that should be XXX% higher IMRX"  
[X Link](https://x.com/SkipperDoodle3/status/1979953964117319834) [@SkipperDoodle3](/creator/x/SkipperDoodle3) 2025-10-19T16:53Z XXX followers, XXX engagements